Literature DB >> 8467455

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

M S Piver1, M F Jishi, Y Tsukada, G Nava.   

Abstract

BACKGROUND: According to previous reports, primary peritoneal carcinoma indistinguishable from primary ovarian adenocarcinoma had developed in five women with a history of familial ovarian cancer who had undergone prophylactic oophorectomy.
METHODS: The records from the Gilda Radner Familial Ovarian Cancer Registry were reviewed for instances of prophylactic oophorectomy and cases of primary peritoneal carcinoma occurring after prophylactic oophorectomy.
RESULTS: From 1981 through July 1992, the Gilda Radner Familial Ovarian Cancer Registry accessioned 931 families (a total of 2221 cases of familial ovarian cancer). Currently, 324 women in these families have undergone prophylactic oophorectomy as a preventive measure against the subsequent development of ovarian cancer. Primary peritoneal carcinoma indistinguishable histologically from primary ovarian adenocarcinoma has developed in six of these women 1-27 years after prophylactic oophorectomy.
CONCLUSIONS: Based on this finding and other reports of such primary peritoneal carcinoma, a prospective international study is planned. This study will compare the incidence of peritoneal carcinoma in first- or second-degree relatives who underwent prophylactic oophorectomy because of a family history of ovarian cancer with that of those who did not undergo prophylactic oophorectomy.

Entities:  

Mesh:

Year:  1993        PMID: 8467455     DOI: 10.1002/1097-0142(19930501)71:9<2751::aid-cncr2820710911>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

Review 1.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

2.  Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.

Authors:  G Landon; J Stewart; M Deavers; K Lu; N Sneige
Journal:  Gynecol Oncol       Date:  2012-03-13       Impact factor: 5.482

3.  Male and female castration.

Authors:  W Foulkes
Journal:  BMJ       Date:  1994-02-05

4.  Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.

Authors:  Ying Chen; Elizabeth Bancroft; Sue Ashley; Audrey Arden-Jones; Sarah Thomas; Susan Shanley; Sibel Saya; Emma Wakeling; Rosalind Eeles
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 5.  Hereditary breast and ovarian cancer: review and future perspectives.

Authors:  Michael P Lux; Peter A Fasching; Matthias W Beckmann
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

Review 6.  Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.

Authors:  R E Heisey; J C Carroll; E Warner; D R McCready; V Goel
Journal:  Can Fam Physician       Date:  1999-01       Impact factor: 3.275

7.  A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.

Authors:  Mark H Greene; Marion Piedmonte; Dave Alberts; Mitchell Gail; Martee Hensley; Zoe Miner; Phuong L Mai; Jennifer Loud; Gustavo Rodriguez; Jack Basil; John Boggess; Peter E Schwartz; Joseph L Kelley; Katie E Wakeley; Lori Minasian; Stephen Skates
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

Review 8.  Development and validation of a protein-based signature for the detection of ovarian cancer.

Authors:  Kyongjin Kim; Irene Visintin; Ayesha B Alvero; Gil Mor
Journal:  Clin Lab Med       Date:  2009-03       Impact factor: 1.935

9.  Prophylactic oophorectomy in Ontario.

Authors:  L Elit; B Rosen; V Goel; J McLaughlin; M K Fung; J Shime; S Narod
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

10.  Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.

Authors:  L Elit; M J Esplen; K Butler; S Narod
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.